Evidence map›Paper›PMID 41188831›Full record

ArticleCardiovascular diabetology2025

Elevated triglyceride-glucose index and its combination with anthropometric indices as indicators of the risk of new-onset transient ischemic attack: a prospective cohort study.

Zhehao Xiao, Ling Luo, Weipin Weng, Erhan Yu, Jiahao Zheng, Xiaodong Pan, Yanping Wang, Rui Wang

Abstract read
In one paragraph

Article in Cardiovascular diabetology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Zhehao Xiao *Neurological Medical Center, Fujian Medical University Union Hospital, Fuzhou, China.
Ling Luo *Neurological Medical Center, Fujian Medical University Union Hospital, Fuzhou, China.
Weipin Weng *Neurological Medical Center, Fujian Medical University Union Hospital, Fuzhou, China.
Erhan YuNeurological Medical Center, Fujian Medical University Union Hospital, Fuzhou, China.
Jiahao ZhengNeurological Medical Center, Fujian Medical University Union Hospital, Fuzhou, China.
Xiaodong PanNeurological Medical Center, Fujian Medical University Union Hospital, Fuzhou, China. pxd77316@163.com.
Yanping WangDepartment of Endocrinology, Fujian Medical University Union Hospital, Fuzhou, China. 447585020@qq.com.
Rui WangNeurological Medical Center, Fujian Medical University Union Hospital, Fuzhou, China. fjxhwr@sina.com.

Funding

Fujian Provincial Health Technology Project Grant No. 2021CXA050Joint Funds for the innovation of science and Technology, Fujian province Grant No. 2021Y9074Technology and Innovation Foundation of Fujian, China Grant No. 2021Y0021the Fujian Provincial Key Clinical Specialty Construction Project Official document No. 884 [2022the Fujian Provincial Natural Science Foundation of China Grant No. 2022J01720the Natural Science Foundation of Fujian Province, China Grant No. 2022J01798the Research Foundation for Advanced Talents of Fujian Medical University Grant No. XRCZX2022009
6 · The paper itself

Abstract

backgroundThe association between the triglyceride-glucose (TyG) and combined anthropometric indices with transient ischemic attack (TIA) has not previously been explored in detail. This study investigated the relationship of TyG and anthropometric indices with incident TIA in healthy populations.

methodsData from a prospective UK Biobank cohort (361,336 participants) were analyzed using Cox regression, population attributable fraction (PAF), restricted cubic splines (RCS), and receiver operating characteristic (ROC) curves. Robustness was evaluated using subgroup and interaction analyses and sensitivity tests.

resultsDuring a median follow-up of 13.7 years, TyG, glucose triglyceride-waist circumference (TyG-WC), glucose triglyceride-body mass index (TyG-BMI), glucose triglyceride-waist height ratio (TyG-WHtR), visceral adiposity index (VAI), and lipid accumulation product (LAP) were significantly associated with increased TIA risk (all P < 0.001). Cox regression analysis revealed that participants in the highest quartile (Q4) had higher hazard ratios (HRs) than those in the lowest quartile (Q1): TyG (HR: 1.22, 95% confidence interval [CI]: 1.12-1.33); TyG-WC (HR: 1.29, 95% CI: 1.17-1.42); TyG-BMI (HR: 1.21, 95% CI: 1.11-1.33); TyG-WHtR (HR: 1.29, 95% CI: 1.18-1.42); VAI (HR: 1.35, 95% CI: 1.24-1.47); and LAP (HR: 1.29, 95% CI: 1.18-1.42). PAF analysis indicated that maintaining Q1 levels of indices for TyG, TyG-WC, TyG-BMI, TyG-WHtR, VAI, and LAP could reduce TIA incidence by 9.07%, 14.56%, 11.48%, 15.75%, 17.18%, and 15.83%, respectively. RCS analysis revealed that TIA risk had linear associations with TyG, TyG-WC, and TyG-BMI, and nonlinear associations with TyG-WHtR, VAI, and LAP (P for nonlinear < 0.05). ROC analysis revealed that the indicators with the highest diagnostic accuracy were TyG-WHtR (area under the curve [AUC] 0.678, 95% CI: 0.676-0.679) and TyG-WC (AUC: 0.673, 95% CI: 0.672-0.675). Subgroup analysis identified age (P < 0.001) and diabetes (P = 0.021) as significant effect modifiers.

conclusionsElevated levels of TyG and combined anthropometric indices are associated with an increased risk of incident TIA. TyG-WHtR and TyG-WC showed a higher accuracy than the TyG index alone as indicators of TIA risk. This study demonstrates the importance of maintaining optimal TyG and anthropometric-related index levels for TIA prevention.

Indexed as

Blood GlucoseIschemic Attack, TransientTriglyceridesWaist CircumferenceAdiposityAdultAgedBiomarkersBody Mass IndexFemaleHumansIncidenceMaleMiddle AgedPredictive Value of TestsPrognosisBiomarkersBlood GlucoseTriglyceridesAnthropometric indicesProspective cohort studyTransient ischemic attackTriglyceride-glucose indexUK BiobankWaist circumferenceWaist-to-height ratio

Identifiers

PMID41188831
PMCPMC12584198

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.